Loading...
XLON
AGR
Market cap2.03bUSD
Oct 03, Last price  
47.48GBP
Name

Assura PLC

Chart & Performance

D1W1MN
XLON:AGR chart
P/E
9.30
P/S
8.40
EPS
0.05
Div Yield, %
5.27%
Shrs. gr., 5y
5.57%
Rev. gr., 5y
10.51%
Revenues
184m
+16.48%
7,016,00016,123,000047,571,00055,761,00062,119,00034,100,00037,100,00039,900,00051,100,00061,000,00071,100,00086,100,000102,400,000111,500,000121,000,000137,300,000152,000,000157,800,000183,800,000
Net income
166m
P
-12,499,00018,900,0000-108,763,000-8,682,00015,072,000-60,700,00014,100,00035,000,00037,200,00027,900,00095,300,00071,800,00084,000,00078,900,000108,300,000155,900,000-119,200,000-28,800,000166,000,000
CFO
111m
+7.91%
2,190,000760,000149,0005,295,000-11,746,0002,859,00013,400,00012,900,0007,900,00016,900,00022,900,00039,000,00049,900,00072,900,00066,300,00077,400,00094,600,00094,100,000102,400,000110,500,000
Dividend
Sep 05, 20240.84 GBP/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.
URL
https://www.assuraplc.com/
IPO date
Jan 28, 2015
Employees
86
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT